热疗联合化疗在胃恶性肿瘤中的疗效分析
摘要
理、增强化疗效果的机制以及局限性与风险，研究热疗联合化疗在胃恶性肿瘤治疗中的临床疗效、不同治疗方案比
较，并提出个体化治疗方案制定、改善热疗设备技术、加强患者监测护理等治疗策略。因此，热疗联合化疗在胃恶
性肿瘤治疗中有一定成效，可为临床治疗提供参考依据，有望改善患者生存率与治疗效果。
关键词
全文:
PDF参考
[1]赵智晨.微波热疗联合化疗治疗晚期消化道肿瘤的
疗效观察[J].中国医疗器械信息，2023，29（02）：93-95.
[2]马骖，林萃，郭燕，等.微波热疗联合化疗及
靶向治疗治疗晚期结直肠癌的临床效果[J].医药前沿，
2024，14（33）：15-17+23.
[3]李岩军.深部热疗联合化疗治疗晚期恶性肿瘤临
床观察[J].转化医学电子杂志，2015，2（12）：33-34.
[4]张华，戚锐锋，张芸，等.全身热疗联合化疗
治疗116例恶性肿瘤患者的临床观察[J].中国医药指南，
2016，14（08）：12-13.
[5]赵其炯，何永越，王道笃.体外高频热疗联合化
疗在局部晚期胸腹部恶性肿瘤中的临床效果[J].中外医学
研究，2021，19（13）：38-40.
[6]Powles T ,Csőszi T ,Loriot Y , et al.Cisplatin- or
Carboplatin-Based Chemotherapy Plus Pembrolizumab in
Advanced Urothelial Cancer: Exploratory Analysis From the
Phase 3 KEYNOTE-361 Study[J].Clinical Genitourinary
Cancer, 2025, 23(1):102261-102261.
[7]Zhao H ,Zhang X ,Tian P , et al.Hepatic arterial
infusion chemotherapy plus regorafenib compared with
regorafenib alone as second-line therapy for advanced
hepatocellular carcinoma: a randomised controlled trial
protocol[J]. BMJ open,2024,14(12):e080805.
[8]Amini N ,Demyan L ,Shah M , et al.Comparison of
neoadjuvant chemotherapy plus radiation vs. chemotherapy
alone on complete pathologic response in pancreatic
adenocarcinoma: an analysis of the national cancer database[J].
Discover Medicine, 2024, 1(1):133-133.
[9]Peng J ,Zhu Z ,Shi M , et al.Chemotherapy
combined with immunotherapy in a patient with multiple
primary gastric and rectal cancers with good prognosis: A case
report[J].Medicine, 2024,103(48):e40699.
[10]Guo X ,Wang J ,Li D , et al.Case report: The
outcomes of neoadjuvant immunotherapy combined with
chemotherapy in pulmonary sarcomatoid carcinoma: case
series and literature review[J].Frontiers in Immunology,
2024,151467755-1467755.
[11]Lazebnik T ,Friedman A .Spatio-temporal model
of combining chemotherapy with senolytic treatment in lung
cancer[J].Mathematical biosciences,2024,379109342.[12]Liu Y ,Xue Y ,Tang J , et al.PorphyrinCamptothecin (CPT) Grafted Polyoxazoline Amphiphiles
for Tumor Photodynamic-Chemotherapy Combination
Treatment[J]. ACS applied materials & interfaces,2024,
[13]Wang B S ,Chen Y J ,Zhao L W , et al.Treatment
Outcomes and Prognostic Factors of Chemotherapy Combined
With Radiation Therapy for Patients With Early-Stage
Extranodal Natural Killer/T-Cell Lymphoma[J].Advances in
Radiation Oncology, 2024, 9(12): 101647-101647.
[14]Zhang Y ,Li J ,Song X , et al.Determining optimal
clinical target volume margins based on microscopic
extracapsular extension of metastatic nodes in patients
with non-small-cell lung cancer after chemotherapy or
chemotherapy combined with immunotherapy[J].BMC
Cancer, 2024, 24(1): 1368-1368.
[15]Zhang Q ,Wang X ,Chen J , et al.Recent
progress of porphyrin metal-organic frameworks for
combined photodynamic therapy and hypoxia-activated
chemotherapy[J]. Chemical communications (Cambridge,
England),2024,
[16]Shang K ,Li T ,Chen Y , et al.Gemcitabine plus
cisplatin versus docetaxel plus cisplatin and fluorouracil
induction chemotherapy combined with locoregional
radiotherapy in de novo metastatic nasopharyngeal carcinoma:
A single center prospective phase II clinical trial[J].Oral
oncology, 2024, 159107087.
Refbacks
- 当前没有refback。
